glp-1 treatment new orleans therapies have reshaped the landscape for type 2 diabetes and obesity but are concerns about muscle loss justified? During ADA 2026 Scientific Sessions, leading experts examined the current evidence, separating Semaglutide in New Orleans |

But an important question these companies must reckon with is whether it is science or scale that is driving their business strategy, says Dr

Because Alzheimers is a complex disease linked to several changes in brain biology, its unlikely that any one treatment would put a full stop to the cognitive decline, says Griffin

Eligible patients (N=135) between the ages of 10-17 years had A1C levels between 7%-11% if they were being treated with diet and exercise alone or between 6.5%-11% if they were being treated with metformin (with or without insulin) and had a body mass index (BMI) greater than the 85th percentile

The colon was cut into small pieces (23 cm in length) and then placed in cold SMB with the composition described previously

Caitlin Beale, MS, RDN Tester Caitlin Beale, MS, RDN, is a registered dietitian and freelance health writer with experience in clinical nutrition, education, research, and private practice